Evidence map›Paper›PMID 40230636›Full record

ReviewRSC advances2025

Iron oxide based magnetic nanoparticles for hyperthermia, MRI and drug delivery applications: a review.

Rizwana Ghazi, Talib K Ibrahim, Jamal Abdul Nasir, Shili Gai, Ghafar Ali, Imed Boukhris, Ziaur Rehman

Abstract readReview
In one paragraph

Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Engineering copper ferrite (CuFeMicrosystems & nanoengineering · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Harnessing the Antimicrobial Potential of Baicalein-Coated FeACS applied materials & interfaces · 2026
    Article
  12. Iron-Based Nanoparticles as Delivery Tools.Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Hybrid FeInternational journal of molecular sciences · 2026
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rizwana GhaziDepartment of Chemistry, Quaid-i-Azam University Islamabad 45320 Pakistan zrehman@qau.edu.pk +92-(051)90642241 +92-(051)90642245.ORCID https://orcid.org/0000-0002-4158-6832
Talib K IbrahimDepartment of Petroleum Engineering, College of Engineering, Knowledge University Erbil Iraq.
Jamal Abdul NasirDepartment of Chemistry, Quaid-i-Azam University Islamabad 45320 Pakistan zrehman@qau.edu.pk +92-(051)90642241 +92-(051)90642245.
Shili GaiKey Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin Engineering University Harbin 150001 P. R. China.
Ghafar AliNanomaterials Research Group (NRG), Physics Division, PINSTECH Nilore Islamabad Pakistan.
Imed BoukhrisDepartment of Physics, Faculty of Science, King Khalid University P. O. Box 9004 Abha Saudi Arabia.
Ziaur RehmanDepartment of Chemistry, Quaid-i-Azam University Islamabad 45320 Pakistan zrehman@qau.edu.pk +92-(051)90642241 +92-(051)90642245.ORCID https://orcid.org/0000-0002-1436-3131

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iron-oxide nanoparticles (IONPs) have garnered substantial attention in both research and technological domains due to their exceptional chemical and physical properties. These nanoparticles have mitigated the adverse effects of conventional treatment procedures by facilitating advanced theranostic approaches in integration with biomedicine. These IONPs have been extensively utilized in MRI (as contrast agents in diagnosis), drug delivery (as drug carriers), and hyperthermia (treatment), demonstrating promising results with potential for further enhancement. This study elucidates the operational principles of these NPs during diagnosis, drug delivery, and treatment, and emphasizes their precision and efficacy in transporting therapeutic agents to targeted sites without drug loss. It also analyses various challenges associated with the application of these IONPs in this field, such as biocompatibility, agglomeration, and toxicity. Furthermore, diverse strategies have been delineated to address these challenges. Overall, this review provides a comprehensive overview of the applications of IONPs in the field of biomedicine and treatment, along with the associated challenges. It offers significant assistance to researchers, professionals, and clinicians in the field of biomedicine.

Identifiers

PMID40230636
PMCPMC11995399

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.